Interplay between K-RAS and miRNAs

Bing Shui1, Gaspare La Rocca2, Andrea Ventura2

  • 1Division of Medical Sciences, Harvard Medical School, Boston, MA, USA; Department of Cancer Biology, Dana-Faber Cancer Institute, Boston, MA, USA; Department of Medicine, Brigham & Women's Hospital, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA.

Trends in Cancer
|January 30, 2022
PubMed

Insights

K-RAS mutations drive cancer by causing overactivation, but feedback mechanisms involving microRNAs (miRNAs) help regulate signaling. This review explores how noncoding RNAs control K-RAS activity, impacting cancer development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • K-RAS mutations are common in cancer, leading to overactivation and oncogene-induced senescence (OIS).
  • Feedback mechanisms regulate K-RAS signaling to balance proliferation and prevent senescence.
  • Aberrant RAS signaling and microRNA (miRNA) dysregulation frequently occur together in various cancers.

Purpose of the Study:

  • To review the current understanding of the interplay between K-RAS signaling and miRNA function.
  • To propose a model for how noncoding RNAs regulate K-RAS signaling pathways.

Main Methods:

  • Literature review of studies on K-RAS, cancer, senescence, and microRNAs.
  • Analysis of existing data on miRNA regulation of K-RAS and vice versa.
  • Synthesis of findings to propose a regulatory model.

Main Results:

  • K-RAS signaling is tightly regulated by feedback loops to maintain cellular homeostasis.
  • MicroRNAs play a significant role in both positively and negatively regulating K-RAS.
  • Evidence suggests a complex network where K-RAS and miRNAs mutually influence each other.

Conclusions:

  • Noncoding RNAs, particularly miRNAs, are integral components of K-RAS regulatory networks.
  • Dysregulation of the K-RAS-miRNA axis contributes to cancer pathogenesis.
  • Understanding this interplay offers potential therapeutic strategies targeting K-RAS-driven cancers.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.4K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K